BofA Lowers its Price Target on Pfizer (PFE) to $26 from $27

Pfizer Inc. (NYSE:PFE) is one of the 8 Cheap Large Cap Stocks to Buy Now. On April 9, 2026, BofA lowered the price target on ...

UBS adjusts pharma outlook, increases Pfizer (PFE) price target

Pfizer Inc. (NYSE:PFE) is included among the 14 Value Stocks with Highest Dividends. On April 13, UBS Group AG raised its price recommendation on Pfizer Inc. (NYSE:PFE) to $27 from $25. It maintained ...
Fintel on MSN

CICC initiates coverage of Pfizer (PFE) with outperform recommendation

Fintel reports that on April 16, 2026, CICC initiated coverage of Pfizer (NYSE:PFE) with a Outperform recommendation. Analyst ...

Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Idexx Laboratories (IDXX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE) and Idexx Laboratories (IDXX). According to TipRanks.com, Tewari is a 5-star analyst with an average ...

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sanofi (OtherSNYNF)

Analysts fell to the sidelines weighing in on Pfizer (PFE) and Sanofi (SNYNF) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. According to TipRanks.com ...

Pfizer’s China Biotech Push Adds New Angle To PFE Valuation Story

Pfizer is seeking drug development partnerships with Chinese biotech companies as local players gain ground on Western peers.